Ellenor Lions Hospices Trading Limited
Annual Report and Financial Statements
For the year ended 31 March 2024
Company Registration No. 05985820 (England and Wales)
Ellenor Lions Hospices Trading Limited
Company Information
Directors
N Springhall
V Heath
(Appointed 6 July 2023)
Company number
05985820
Registered office
Ellenor
Coldharbour Road
Northfleet
Kent
DA11 7HQ
Auditor
Moore Kingston Smith LLP
Orbital House
20 Eastern Road
Romford
Essex
RM1 3PJ
Ellenor Lions Hospices Trading Limited
Contents
Page
Directors' report
1 - 2
Independent auditor's report
3 - 7
Statement of comprehensive income
8
Balance sheet
9
Notes to the financial statements
11 - 14
Ellenor Lions Hospices Trading Limited
Directors' Report
For the year ended 31 March 2024
Page 1

The directors present their annual report and financial statements for the year ended 31 March 2024.

Principal activities

The principal activity of the company continued to be that of the sale of new and donated goods and the running of a cafe.

Results and dividends

The results for the year are set out on page 8.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

N Springhall
A R Wedderburn-Day
(Resigned 19 September 2023)
V Heath
(Appointed 6 July 2023)
Auditor

Moore Kingston Smith LLP were appointed as auditor to the company and in accordance with section 485 of the Companies Act 2006, a resolution proposing that they be re-appointed will be put at a General Meeting.

Statement of directors' responsibilities

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

 

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

Ellenor Lions Hospices Trading Limited
Directors' Report (Continued)
For the year ended 31 March 2024
Page 2
Small companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

On behalf of the board
N Springhall
Director
14 August 2024
Ellenor Lions Hospices Trading Limited
Independent Auditor's Report
To the Members of Ellenor Lions Hospices Trading Limited
Page 3
Opinion

We have audited the financial statements of Ellenor Lions Hospices Trading Limited (the 'company') for the year ended 31 March 2024 which comprise the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report, other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

 

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Ellenor Lions Hospices Trading Limited
Independent Auditor's Report (Continued)
To the Members of Ellenor Lions Hospices Trading Limited
Page 4

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the directors' report. We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

 

Responsibilities of directors

As explained more fully in the Directors' Responsibilities Statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

 

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Ellenor Lions Hospices Trading Limited
Independent Auditor's Report (Continued)
To the Members of Ellenor Lions Hospices Trading Limited
Page 5
Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

 

As part of an audit in accordance with ISAs (UK) we exercise professional judgement and maintain professional scepticism throughout the audit. We also:

 

 

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

 

 

Ellenor Lions Hospices Trading Limited
Independent Auditor's Report (Continued)
To the Members of Ellenor Lions Hospices Trading Limited
Page 6

Explanation as to what extent the audit was considered capable of detecting irregularities, including fraud

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.

The objectives of our audit in respect of fraud, are; to identify and assess the risks of material misstatement of the financial statements due to fraud; to obtain sufficient appropriate audit evidence regarding the assessed risks of material misstatement due to fraud, through designing and implementing appropriate responses to those assessed risks; and to respond appropriately to instances of fraud or suspected fraud identified during the audit. However, the primary responsibility for the prevention and detection of fraud rests with both management and those charged with governance of the company.

Our approach was as follows:

 

 

There are inherent limitations in the audit procedures described above. We are less likely to become aware of instances of non-compliance with laws and regulations that are not closely related to events and transactions reflected in the financial statements. Also, the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Ellenor Lions Hospices Trading Limited
Independent Auditor's Report (Continued)
To the Members of Ellenor Lions Hospices Trading Limited
Page 7
Karen Wardell
Senior Statutory Auditor
for and on behalf of Moore Kingston Smith LLP
14 August 2024
Chartered Accountants
Statutory Auditor
Orbital House
20 Eastern Road
Romford
Essex
RM1 3PJ
Ellenor Lions Hospices Trading Limited
Statement of Comprehensive Income
For the year ended 31 March 2024
Page 8
2024
2023
£
£
Turnover
294,659
230,504
Cost of sales
(206,838)
(172,328)
Gross profit
87,821
58,176
Administrative expenses
(61,689)
(46,804)
Profit before taxation
26,132
11,372
Tax on profit
-
0
-
0
Profit for the financial year
26,132
11,372
Ellenor Lions Hospices Trading Limited
Balance Sheet
As at 31 March 2024
Page 9
2024
2023
Notes
£
£
£
£
Current assets
Stock
11,167
13,508
Cash at bank and in hand
12,619
12,722
23,786
26,230
Creditors: amounts falling due within one year
3
(13,785)
(40,757)
Net current assets/(liabilities)
10,001
(14,527)
Creditors: amounts falling due after more than one year
4
(10,000)
-
0
Net assets/(liabilities)
1
(14,527)
Capital and reserves
Called up share capital
5
1
1
Profit and loss reserves
-
0
(14,528)
Total equity
1
(14,527)

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 14 August 2024 and are signed on its behalf by:
N  Springhall
Director
Company Registration No. 05985820
Ellenor Lions Hospices Trading Limited
Statement of Changes in Equity
For the year ended 31 March 2024
Page 10
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 April 2022
1
(25,900)
(25,899)
Year ended 31 March 2023:
Profit and total comprehensive income for the year
-
11,372
11,372
Balance at 31 March 2023
1
(14,528)
(14,527)
Year ended 31 March 2024:
Profit and total comprehensive income for the year
-
26,132
26,132
Distributions to parent charity under gift aid
-
(11,604)
(11,604)
Balance at 31 March 2024
1
-
0
1
Ellenor Lions Hospices Trading Limited
Notes to the Financial Statements
For the year ended 31 March 2024
Page 11
1
Accounting policies
Company information

Ellenor Lions Hospices Trading Limited is a private company limited by shares incorporated in England and Wales. The registered office is Ellenor Coldharbour Road, Northfleet, Kent, DA11 7HQ.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention.The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.3
Stock

Stock is stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stock to their present location and condition.

 

Stock held for distribution at no or nominal consideration is measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stock over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

Ellenor Lions Hospices Trading Limited
Notes to the Financial Statements (Continued)
For the year ended 31 March 2024
1
Accounting policies
(Continued)
Page 12
1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Ellenor Lions Hospices Trading Limited
Notes to the Financial Statements (Continued)
For the year ended 31 March 2024
1
Accounting policies
(Continued)
Page 13
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
2
2
3
Creditors: amounts falling due within one year
2024
2023
£
£
Amounts owed to group undertakings
13,785
40,757
4
Creditors: amounts falling due after more than one year
2024
2023
£
£
Amounts owed to group undertakings
10,000
-
Ellenor Lions Hospices Trading Limited
Notes to the Financial Statements (Continued)
For the year ended 31 March 2024
Page 14
5
Called up share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
of £1 each
1
1
1
1
6
Related party transactions

£11,604 (2023: £Nil) was distributed under gift aid to the parent undertaking, ellenor. At the year end £23,785 (2023: £40,757) was due to the parent undertaking.

 

During 2024, after careful consideration the parent undertaking agreed a renewal of a 5 year loan agreement to the company of £10,000. The extended loan expires on 31 March 2028 and bears interest at 2% above the Bank of England base rate. This interest has been recognised though management charges in the year.

7
Parent company

The ultimate parent company throughout the year was ellenor, a charitable company incorporated in England and Wales. Its registered office is disclosed in note 1. Group financial statements for ellenor are available to the public from the registered office.

2024-03-312023-04-01falseCCH SoftwareCCH Accounts Production 2024.100N SpringhallA R Wedderburn-DayV HeathK C J Barraballfalsefalse059858202023-04-012024-03-3105985820bus:RegisteredOffice2023-04-012024-03-3105985820bus:Director12023-04-012024-03-3105985820bus:Director22023-04-012024-03-3105985820bus:Director32023-04-012024-03-3105985820bus:Director42023-04-012024-03-31059858202024-03-31059858202022-04-012023-03-3105985820core:RetainedEarningsAccumulatedLosses2022-04-012023-03-3105985820core:RetainedEarningsAccumulatedLosses2023-04-012024-03-31059858202023-03-3105985820core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3105985820core:CurrentFinancialInstrumentscore:WithinOneYear2023-03-3105985820core:Non-currentFinancialInstrumentscore:AfterOneYear2024-03-3105985820core:Non-currentFinancialInstrumentscore:AfterOneYear2023-03-3105985820core:ShareCapital2024-03-3105985820core:ShareCapital2023-03-3105985820core:RetainedEarningsAccumulatedLosses2024-03-3105985820core:RetainedEarningsAccumulatedLosses2023-03-3105985820core:ShareCapital2022-03-3105985820core:RetainedEarningsAccumulatedLosses2022-03-31059858202022-03-3105985820core:CurrentFinancialInstruments2024-03-3105985820core:CurrentFinancialInstruments2023-03-3105985820bus:PrivateLimitedCompanyLtd2023-04-012024-03-3105985820bus:FRS1022023-04-012024-03-3105985820bus:Audited2023-04-012024-03-3105985820bus:FullAccounts2023-04-012024-03-31xbrli:purexbrli:sharesiso4217:GBP